Search results - Portal of Medical Data Models (MDM-Portal)

Filter search results

Keywords

Pruritus ×

Show more Keywords

Table of contents

Select data models

Selected data models

You must log in to select data models for download or further analysis.

22 Search results.

EADV PruNet - Pruritus Intensity Scales (VAS, NRS, VRS)

- 5/6/15 - 1 form, 1 itemgroup, 6 items, 7 languages

Itemgroup: Pruritus intensity scales

Phan NQ, Blome C, Fritz F, Gerss J, Reich A, Ebata T, Augustin M, Szepietowski JC, Ständer S. Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol. 2012 Sep;92(5):502-7 http://www.ncbi.nlm.nih.gov/pubmed/22170091

Eligibility NCT00980629 Atopic Dermatitis - Eligibility

- 9/20/21 - 1 form, 2 itemgroups, 19 items, 2 languages

Itemgroups: Inclusion Criteria,Exclusion Criteria

ODM derived from http://clinicaltrials.gov/show/NCT00980629

Eligibility NCT00669708 Compensate the Roughness of the Skin - Eligibility

- 9/20/21 - 1 form, 2 itemgroups, 9 items, 2 languages

Itemgroups: Inclusion Criteria,Exclusion Criteria

ODM derived from http://clinicaltrials.gov/show/NCT00669708

Itchy QoL University Hospital Muenster (UKM)

- 11/2/17 - 1 form, 3 itemgroups, 25 items, 1 language

Itemgroups: General information,Frequencies of symptoms during the last week,Frequencies of symptoms during the last four weeks

Hospital Routine Documentation Form at the University Hospital Muenster. Original Form name: Itchy QoL. Original English Version developed by: N.S. Desai, G.B. Poindexter, Y.M. Monthrope, S.E. Bendeck, R.A. Swerlick, S.C. ChenA pilot quality-of-life instrument for pruritus J Am Acad Dermatol, 59 (2008), pp. 234-244 German version developed by K. Krause, B. Kessler, K. Weller, J. Veidt, S.C. Chen, P. Martus, et al.German version of ItchyQoL: validation and initial clinical findings Acta Derm Venereol, 93 (2013), pp. 562-568

Pruritus Visual Analogue Scale (VAS) Week 36 Mepolizumab HES NCT00086658 - Pruritus Visual Analogue Scale (VAS) Week 36

- 7/15/17 - 1 form, 1 itemgroup, 2 items, 1 language

Itemgroup: Assessment using visual analog scale Pruritus

Study part: Pruritus Visual Analogue Scale (VAS) Week 36/ Early Withdrawal Visit.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Pruritus Visual Analogue Scale (VAS) Week 32 Mepolizumab HES NCT00086658 - Pruritus Visual Analogue Scale (VAS) Week 32

- 6/5/17 - 1 form, 1 itemgroup, 2 items, 1 language

Itemgroup: Assessment using visual analog scale Pruritus

Study part: Pruritus Visual Analogue Scale (VAS) Week 32.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Pruritus Visual Analogue Scale (VAS) Week 38 Mepolizumab HES NCT00086658 - Pruritus Visual Analogue Scale (VAS) Week 38

- 6/5/17 - 1 form, 1 itemgroup, 2 items, 1 language

Itemgroup: Assessment using visual analog scale Pruritus

Study part: Pruritus Visual Analogue Scale (VAS) Week 38.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Pruritus Visual Analogue Scale (VAS) Week 28 Mepolizumab HES NCT00086658 - Pruritus Visual Analogue Scale (VAS) Week 28

- 6/5/17 - 1 form, 1 itemgroup, 2 items, 1 language

Itemgroup: Assessment using visual analog scale Pruritus

Study part: Pruritus Visual Analogue Scale (VAS) Week 28.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Pruritus Visual Analogue Scale (VAS) Week 24 Mepolizumab HES NCT00086658 - Pruritus Visual Analogue Scale (VAS) Week 24

- 6/5/17 - 1 form, 1 itemgroup, 2 items, 1 language

Itemgroup: Assessment using visual analog scale Pruritus

Study part: Pruritus Visual Analogue Scale (VAS) Week 24.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Pruritus Visual Analogue Scale (VAS) Week 12 Mepolizumab HES NCT00086658 - Pruritus Visual Analogue Scale (VAS) Week 12

- 6/5/17 - 1 form, 1 itemgroup, 2 items, 1 language

Itemgroup: Assessment using visual analog scale Pruritus

Study part: Pruritus Visual Analogue Scale (VAS) Week 12.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Pruritus Visual Analogue Scale (VAS) Week 16 Mepolizumab HES NCT00086658 - Pruritus Visual Analogue Scale (VAS) Week 16

- 6/5/17 - 1 form, 1 itemgroup, 2 items, 1 language

Itemgroup: Assessment using visual analog scale Pruritus

Study part: Pruritus Visual Analogue Scale (VAS) Week 16.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Pruritus Visual Analogue Scale (VAS) Week 20 Mepolizumab HES NCT00086658 - Pruritus Visual Analogue Scale (VAS) Week 20

- 6/5/17 - 1 form, 1 itemgroup, 2 items, 1 language

Itemgroup: Assessment using visual analog scale Pruritus

Study part: Pruritus Visual Analogue Scale (VAS) Week 20.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Please use this form for feedback, questions and suggestions for improvements.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.